Journal Mobile Options
Table of Contents
Vol. 6, No. 4, 2000
Issue release date: December 2000
Eur Addict Res 2000;6:170–182

The Early Developmental Stages of Psychopathology Study (EDSP): A Methodological Update

Lieb R. · Isensee B. · von Sydow K. · Wittchen H.-U.
Clinical Psychology and Epidemiology Unit, Max Planck Institute of Psychiatry, Munich, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The objectives of the community-based Early Developmental Stages of Psychopathology (EDSP) Study are described along with a detailed account of the overall design, special design features, sample characteristics and instruments used. The EDSP employed a prospective-longitudinal design to study substance use and other mental disorders in a representative population sample of 3,021 subjects aged 14–24 years (birth cohorts 1970–1981) at ‘baseline’ – the outset of the study. Two follow-up investigations were conducted after the baseline investigation covering an overall period of 3–4 years. Special design features are the linkage with a family supplement (EDSP-FS) as well as neurobiological laboratory studies of high-risk subjects.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Nelson CB, Wittchen H-U: The EDSP: Setting the stage! (editorial). Eur Addict Res 1998;4: 5–7.
  2. Research Group ANEPSA: Epidemiological research in Germany. Eur Addict Res 1998;4:203–204.
  3. John U: Analytische Epidemiologie des Substanzmissbrauchs in Deutschland (editorial). Sucht 2000;46:6–8.
  4. Küfner H, Schumann J, Duwe A, Bühringer G: Project 1: Longitudinal risk cohort study on the onset, course, prevalence and prevention of illegal drug abuse. Eur Addict Res 1998;4:205–206.
  5. Lieb R, Schuster P, Pfister H, Wunderlich Z, Holly A, Mastaler M, Sonntag H, Gander F, Höfler M, Lachner G, Perkonigg A, Garczynski E, Türk D, Wittchen H-U: Projects 2 and 3: Vulnerability and protective factors in early developmental stages of substance use disorders. Eur Addict Res 1998;4:206–207.
  6. Hapke U, Rumpf H-J, Meyer C, Dilling H, John U: Project 4: Substance use, abuse and dependence among the adult population in a rural and urban region of Northern Germany. Eur Addict Res 1998;4:208–209.
  7. Rumpf H-J, Hapke U, Dawedeit A, Meyer C, John U: Project 5: Triggering and maintenance factors of remitting from alcohol dependence without formal help. Eur Addict Res 1998;4:209–210.
  8. Wittchen H-U, Nelson GB, Lachner G: Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998;28:109–126.
  9. Wittchen H-U, Lieb R, Perkonigg A: Early developmental stages of substance abuse and dependence: Examples from a prospective longitudinal study; in Ladewig D (ed): Basic and Clinical Science of Substance-Related Disorders. Bibl Psychiatr. Basel, Karger, 1999, pp 7–22.
  10. Wittchen H-U, Lieb R, Schuster P, Oldehinkel T: When is onset? Investigations into early developmental stages of anxiety and depressive disorders; in Rapoport JL (ed): Childhood Onset of ‘Adult’ Psychopathology, Clinical and Research Advances. Washington, American Psychiatric Press, 1999, pp 259–302.
  11. Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen H-U: Epidemiologie des Konsums, Missbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: Die prospektiv-longitudinale Verlaufsstudie EDSP. Sucht 2000;46:18–31.
  12. Rumpf H-J, Meyer Ch, Hapke U, Bischof G, John U: Inanspruchnahme suchtspezifischer Hilfen von Alkoholabhängigen und -missbrauchern: Ergebnisse der TACOS-Bevölkerungsstudie. Sucht 2000;46:9–17.
  13. Küfner H, Duwe A, Schumann J, Bühringer G: Prädiktoren des Drogenkonsums und der Suchtentwicklung durch Faktoren in der Kindheit: Grundlagen und Ergebnisse einer empirischen Studie. Sucht 2000;46:32–53.
  14. Bischof G, Rumpf H-J, Hapke U, Meyer C, John U: Remission ohne formelle Hilfen und Inanspruchnahme stationärer Behandlung bei Alkoholabhängigen: Ein Vergleich auslösender Faktoren. Sucht 2000;46:54–61.
  15. Perkonigg A, Lieb R, Wittchen H-U: Substance use, abuse and dependence in Germany: A review of selected epidemiological data. Eur Addict Res 1998;4:8–17.
  16. Wittchen H-U, Perkonigg A, Lachner G, Nelson CB: Early developmental stages of psychopathology study (EDSP): Objectives and design. Eur Addict Res 1998;4:18–27.
  17. Lachner G, Wittchen H-U, Perkonigg A, Holly A, Schuster P, Wunderlich U, Türk D, Garczynski E, Pfister H: Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI): Substance use sections. Eur Addict Res 1998;4:28–41.
  18. Nelson CB, Wittchen H-U: Smoking and nicotine dependence: Results from a sample of 14- to 24-year-olds in Germany. Eur Addict Res 1998;4:42–49.
  19. Holly A, Wittchen H-U: Patterns of use and their relationship to DSM-IV abuse and dependence of alcohol among adolescents and young adults. Eur Addict Res 1998;4:50–57.
  20. Perkonigg A, Lieb R, Wittchen H-U: Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. Eur Addict Res 1998;4:58–66.
  21. Lieb R, Pfister H, Wittchen H-U: Use, abuse and dependence of prescription drugs in adolescents and young adults. Eur Addict Res 1998;4:67–74.
  22. Schuster P, Lieb R, Lamertz C, Wittchen H-U: Is the use of ecstasy and hallucinogens increasing? Results from a community study. Eur Addict Res 1998;4:75–82.
  23. Schuster P, Wittchen HU: Ecstasy- und Halluzinogengebrauch bei Jugendlichen: Gibt es eine Zunahme? Verhaltenstherapie 1996;6:222–232.
  24. Holly A, Türk D, Nelson CB, Pfister H, Wittchen H-U: Prävalenz von Alkoholkonsum, Alkoholmissbrauch und -abhängigkeit bei Jugendlichen und jungen Erwachsenen. Z Klin Psychol 1997;26:171–178.
  25. Perkonigg A, Beloch E, Garczynski E, Nelson CB, Pfister H, Wittchen H-U: Prävalenz von Drogenmissbrauch und -abhängigkeit bei Jugendlichen und jungen Erwachsenen: Gebrauch, Diagnosen und Auftreten erster Missbrauchs- und Abhängigkeitsmerkmale. Z Klin Psychol 1997;26:247–257.
  26. Wittchen H-U, Höfler M, Perkonigg A, Sonntag H, Lieb R: Wie stabil sind Drogenkonsum und das Auftreten klinisch-diagnostisch relevanter Missbrauchs- und Abhängigkeitsstadien be Jugendlichen? Eine epidemiologische Studie am Beispiel von Cannabis. Kindheit Entwicklung 1998;7:188–198.
  27. Höfler M, Lieb R, Perkonigg A, Schuster P, Sonntag H, Wittchen H-U: Covariates of cannabis use progression in a representative population sample of adolescents: A prospective examination of vulnerability and risk factors. Addiction 1999;94:1679–1694.
  28. Perkonigg A, Lieb R, Höfler M, Schuster P, Sonntag H, Wittchen H-U: Patterns of cannabis use, abuse and dependence over time: Incidence, progression and stability in a sample of 1,228 adolescents. Addiction 1999;94:1663–1678.
  29. Sonntag H, Wittchen H-U, Höfler M, Kessler RC, Stein MB: Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults. Eur Psychiatry 2000;15:67–75.
  30. Wittchen H-U, Pfister H (eds): DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-12 Monate); Ergänzungsheft (DIA-X-12 Monate); PC-Programm zur Durchführung des Interviews (Längs- und Querschnittuntersuchung); Auswertungsprogramm. Frankfurt, Swets & Zeitlinger, 1997.
  31. World Health Organization: Composite International Diagnostic Interview (CIDI). Geneva, World Health Organization, Division of Mental Health, 1990.
  32. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
  33. World Health Organization: International Classification of Diseases, rev 10. Geneva, World Health Organization, Division of Mental Health, 1994.
  34. Wittchen H-U, Lachner G, Wunderlich U, Pfister H: Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998;33:568–578.
  35. Reed V, Gander F, Pfister H, Steiger A, Sonntag H, Trenkwalder C, Hundt W, Wittchen H-U: To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM-IV disorders? Testing validity issues in a clinical sample. Int J Methods Psychiatr Res 1998;7:142–155.
  36. Lachner G, Wittchen H-U: Das Composite International Diagnostic Interview Substance Abuse Module (CIDI-SAM); in Mann K, Buchkremer G (eds): Sucht: Grundlagen, Diagnostik, Therapie. Stuttgart, Fischer, 1996, pp 147–156.
  37. Dlugosch GE, Krieger W: Fragebogen zur Erfassung des Gesundheitsverhaltens. Frankfurt am Main, Swets, 1994.
  38. Leigh BC, Stacy AW: Alcohol outcome expectancies: Scale construction and predictive utility in higher order confirmatory models. Psychol Assess 1993;5:216–229.

    External Resources

  39. Derogatis LR: SCL-90-R: Self-Report Symptom Inventory. Weinheim, Beltz, 1986.
  40. Maier-Diewald W, Wittchen H-U, Hecht H, Werner-Eilert K: Die Münchner Ereignisliste (MEL) – Anwendungsmanual. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1983.
  41. Lachner G, Wittchen H-U: Skala zum Vergleich von Kompetenzen. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1995.
  42. Schauder Th: Die Aussagenliste zum Selbstwertgefühl für Kinder und Jugendliche. Weinheim, Beltz, 1991.
  43. Perkonigg A, Wittchen H-U: Problemlösekompetenz-Skala: Forschungsversion. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1995.
  44. Reznick JS, Hegeman JM, Kaufman ER, Woods SW, Jacobs M: Retrospective and concurrent self-report of behavioral inhibition and their relation to adult mental health. Dev Psychopathol 1992;4:301–321.
  45. Perkonigg A, Wittchen H-U: The Daily-Hassles Scale: Forschungsversion. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1995.
  46. Schumacher J, Eisemann M, Brähler E: Rückblick auf die Eltern: Der Fragebogen zum erinnerten elterlichen Erziehungsverhalten (FEE). Diagnostica 1999;45:194–204.

    External Resources

  47. Bohner G, Hormuth SE, Schwarz N: Die Stimmungsskala: Vorstellung und Validierung einer deutschen Version des ‘Mood Survey’. Diagnostica 1991;37:135–148.
  48. Harvey PD, Greenberg BR, Serper MR: The affective lability scales: Development, reliability, and validity. J Clin Psychol 1989;45:786–793.

    External Resources

  49. Wagnild GM, Young HM: Development and psychometric evaluation of the resilience scale. J Nurs Manag 1993;1:165–178.
  50. Kuhl J, Fuhrmann A: Selbststeuerungs-Inventar: SSI (Kurzversion). Universität Osnabrück, Vorpublikationsabzug, 1997.
  51. Wittchen H-U: Premenstrual Symptom Scale: Forschungsversion. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1995.
  52. Addis ME, Truax P, Jacobson NS: Why do people think they are depressed? The reasons for depression questionnaire. Psychotherapy 1995;32:476–483.
  53. Wunderlich U, Wittchen H-U: Fragebogen zu Selbstmordversuchen. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1998.
  54. Wittchen H-U: Erleben des ersten Angstanfalls. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1997.
  55. Fydrich T, Renneberg B, Schmitz B, Wittchen H-U: SKID II: Strukturiertes Klinisches Interview für DSM-IV (SKID-II), Achse II: Persönlichkeitsstörungen. Eine deutschsprachige, erweiterte Bearbeitung der amerikanischen Originalversion des SCID-II von First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L (Version 3/96). Göttingen, Hogrefe, 1997.
  56. Cohen PR: The effects of instruments and informants on ascertainment; in Dunner DL, Gershon ES, Barrett JE (eds): Relatives at risk for mental disorder. New York, Raven Press, 1988, pp 31–52.
  57. Andreasen NC, Rice J, Endicott J, Reich T, Coryell W: The family history approach to diagnosis: How useful is it? Arch Gen Psychiatry 1986;43:421–429.
  58. Rice JP, Reich Th, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, Hesselbrock VM, Nurnberger JI, Schuckit MA, Begleiter H: Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 1995;19:1018–1023.
  59. Kendler KS, Roy M-A: Validity of a diagnosis of lifetime major depression obtained by personal interview versus family history. Am J Psychiatry 1995;152:1608–1614.
  60. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria: Reliability and validity. Arch Gen Psychiatry 1977;34:229–235.
  61. Lieb R, Wittchen H-U, Höfler M, Fuetsch M, Stein M, Merikangas KR: Parental psychopathology, parenting styles and the risk of social phobia in offspring: A prospective-longitudinal community study. Arch Gen Psychiatry 2000;57:859–866.
  62. Lachner G, Wittchen H-U: Münchener Composite International Diagnostic Interview, M-CIDI (familiengenetische Version), Elternbefragung, Version 2.0. München, Pax-Planck-Institut für Psychiatrie, Eigendruck, 1997.
  63. Epstein NB, Baldwin LM, Bishop DS: The McMaster Family Assessment Device. J Marriage Fam Ther 1983;9:171–180.
  64. Lachner G, Wittchen H-U: Skala elterli- cher Erziehungsmassnahmen EMAS-P: Forschungsversion. München, Max-Planck-Institut für Psychiatrie, Eigendruck, 1997.
  65. Mattejat F: Subjektive Familienstrukturen. Untersuchungen zur Wahrnehmung der Familienbeziehungen und zu ihrer Bedeutung für die psychische Gesundheit von Jugendlichen. Göttingen, Hogrefe, 1993.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50